Comparative Effectiveness research on Psychiatric HOSpitalisation by record LINKage of large administrative data sets
Randomised controlled trial to evaluate electronic Symptom Management using the Advanced Symptom Management System (ASyMS) Remote Technology for patients with cancers
Disarming the intravascular innate immune response to improve treatment modalities for chronic kidney disease
Targeted Action for Curing Trauma Induced Coagulopathy
-
Social innovation to improve physical activity and sedentary behaviour through elite European football clubs: European Fans in Training
Universal Influenza Vaccines Secured
Collaborative European NeuroTrauma Effectiveness Research in TBI
Optimizing Exercise Training in Prevention and Treatment of Diastolic Heart Failure
IMAging GEnetics for MENtal Disorders
A “Universal” Influenza Vaccine through Synthetic, Dendritic Cell-Targeted, Self-Replicating RNA Vaccines
A new therapeutic antibody with a personalised medicine approach in cardiovascular disease
Supporting Low-cost Intervention For disEase control
Improving Outcome of Necrotizing Fasciitis: Elucidation of Complex Host and Pathogen Signatures that Dictate Severity of Tissue Infection
Diagnosis and Monitoring of Inflammatory and Arthritic diseases using a COmbined approach Based on Ultrasound, optoacoustic and hyperSpectral imaging
Inflammatory Bowel Disease CHARACTERization by a multi-modal integrated biomarker study
Clinical tRials fOr elderly patients with MultiplE Disease
Health Care Reform: the iMpact on practice, oUtcomes and costs of New roles for health pROfeSsionals
New approach to treatment of the blinding disease Retinopathy of Prematurity (ROP)
Adopting Hospital Based Health Technology Assessment in EU
Sustainable prevention of obesity through integrated strategies
Genomic and lifestyle predictors of foetal outcome relevant to diabetes and obesity and their relevance to prevention strategies in South Asian peoples.
EPIC-CVD: Individualised CVD risk assessment: tailoring targeted and cost-effective approaches to Europe's diverse populations
CAncer Risk and INsulin analoGues
